Developing Patient-Derived Organ-on-a-Chip Models to Better Predict Patient Response
- Discussing the use of organ-on-a-chip models to better mimic the tumour microenvironment and cellular interactions
- Exploring the integration of multiple cell types, including immune cells and stromal cells, to create more physiologically relevant models that are reproducible and capture patient heterogeneity
- Validating a mouse breast cancer organ-on-a-chip model with mouse models to uncover their translational relevance and sharing considerations in drug development